Table: Taiko Pharmaceutical -Q1 group results

Taiko Pharmaceutical

12/08/2016 07:00

Aug 12 (Reuters)-  
             Taiko Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   3 months ended      3 months ended       Year to  
                  Jun 30, 2016        Jun 30, 2015     Mar 31, 2017  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               1.04                1.43             8.40      
                   (-27.2 pct)         (-1.7 pct)       (+0.9 pct)   
  Operating           3 mln              150 mln           1.35      
                   (-97.5 pct)         (-63.7 pct)      (+0.2 pct)   
  Recurring        loss 91 mln           170 mln           1.11      
                                       (-58.5 pct)      (-15.1 pct)  
  Net              loss 35 mln           50 mln           850 mln    
                                       (-81.4 pct)      (+1.2 pct)   
  EPS             loss 2.71 yen         3.96 yen         65.24 yen   
  EPS Diluted                           3.86 yen                     
  Ann Div                               15.00 yen        15.00 yen   
  -Q2 div                                  NIL              NIL      
  -Q4 div                               15.00 yen        15.00 yen   
   
  NOTE - Taiko Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T  
  ((Tokyo Headline News Desk +813 6441 1812))